A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Conditions: Healthy Subjects Interventions: Drug: AP303 150 μg; Drug: Placebo 150 μg; Drug: AP303 300 μg; Drug: Placebo 300 μg Sponsors: Alebund Pharmaceuticals Not yet recruiting

https://clinicaltrials.gov/study/NCT06308523

Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

More News: China Health | Research | Study